Sign Up to like & get
recommendations!
1
Published in 2018 at "European Journal of Pharmacology"
DOI: 10.1016/j.ejphar.2018.10.007
Abstract: ABSTRACT The latest molecular investigations leading to the discovery of the brand‐new mechanisms associated to immortalized nature of cancer cells have questioned the efficacy of the conventional therapies and have increased the demand for more…
read more here.
Keywords:
pi3k;
bkm120;
ato;
inhibition ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Neuro-oncology"
DOI: 10.1093/neuonc/nox168.061
Abstract: BACKGROUND c-MET and PI3K pathways are dysregulated in GBM and can drive cancer growth in pre-clinical models. INC280 is a small molecule inhibitor of c-MET; BKM120 is a pan-class I PI3K inhibitor. A phase Ib/II study was designed…
read more here.
Keywords:
phase;
bkm120;
study;
phase open ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.mct-16-0683
Abstract: We previously reported that the EGFR-targeted inhibitor erlotinib induces G1 arrest of squamous cell carcinoma of the head and neck (SCCHN) cell lines without inducing significant apoptosis. Large-scale genomic studies suggest that >50% of SCCHN…
read more here.
Keywords:
pi3k;
apoptosis;
bkm120;
cell lines ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0179948
Abstract: Medulloblastoma (MB) is the most common malignant brain tumor in children, accounting for nearly 20 percent of all childhood brain tumors. New treatment strategies are needed to improve patient survival outcomes and to reduce adverse…
read more here.
Keywords:
tumor growth;
cell lines;
cell;
bkm120 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Oncology Reports"
DOI: 10.3892/or.2018.6716
Abstract: Triple-negative breast cancer (TNBC) refers to a heterogeneous group of tumors, for which there is currently a lack of targeted therapies. Poly(ADP-ribose) polymerase (PARP) inhibitors, phosphatidylinositol 3-kinase (PI3K) inhibitors and carboplatin (CBP) have demonstrated sufficient…
read more here.
Keywords:
combination;
negative breast;
bkm120;
breast cancer ... See more keywords